I like your numbers. I feel it will be lower on revenue due to the recent guidance but the exponential acceleration in top line growth will occur this year and I’m more bullish now that the market has had a few years to really immerse in the benefits. Aligned with your comment on battling through the storms and that is a test to the solution offering.
check out this doctor presentation where they call the patient results remarkable!
this consistent feedback should create a strong flywheel for the business moving forward.
https://m.youtube.com/watch?v=kHyoLpt0tKM
Ann: XPERIENCE study findings published, page-21
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.015(6.12%) |
Mkt cap ! $75.84M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.5¢ | 24.5¢ | $20.20K | 79.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9313 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 24500 | 1 |
View Market Depth
| Last trade - 15.30pm 20/06/2024 (20 minute delay) ? |
| NXS (ASX) Chart |